Australia Stock Exchange release from EMYRIA : Phase 1 trial commences Q1, 2022 for Emyrias ultra-pure CBD
19/01/2022 22:41
Australia Stock Exchange release from EMYRIA EMD.AX : Phase 1 trial commences Q1, 2022 for Emyrias ultra-pure CBD
- AU$30.65m
- AU$24.15m
- AU$4.05m